| Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients C Bergamaschi, E Terpos, M Rosati, M Angel, J Bear, D Stellas, ... Cell reports 36 (6), 2021 | 210 | 2021 |
| A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2 K Sidera, M Gaitanou, D Stellas, R Matsas, E Patsavoudi Journal of Biological Chemistry 283 (4), 2031-2041, 2008 | 203 | 2008 |
| VEGF Signals through ATF6 and PERK to promote endothelial cell survival and angiogenesis in the absence of ER stress E Karali, S Bellou, D Stellas, A Klinakis, C Murphy, T Fotsis Molecular cell 54 (4), 559-572, 2014 | 200 | 2014 |
| Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell … D Stellas, A El Hamidieh, E Patsavoudi BMC cell biology 11 (1), 1-9, 2010 | 179 | 2010 |
| Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson’s disease G Kouroupi, E Taoufik, IS Vlachos, K Tsioras, N Antoniou, ... Proceedings of the National Academy of Sciences 114 (18), E3679-E3688, 2017 | 163 | 2017 |
| Scalable, cGMP-compatible purification of extracellular vesicles carrying bioactive human heterodimeric IL-15/lactadherin complexes DC Watson, BC Yung, C Bergamaschi, B Chowdhury, J Bear, D Stellas, ... Journal of extracellular vesicles 7 (1), 1442088, 2018 | 153 | 2018 |
| Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10 C Bergamaschi, H Pandit, BA Nagy, D Stellas, SM Jensen, J Bear, M Cam, ... Journal for immunotherapy of cancer 8 (1), 2020 | 114 | 2020 |
| Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis D Stellas, A Karameris, E Patsavoudi Clinical Cancer Research 13 (6), 1831-1838, 2007 | 95 | 2007 |
| Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer D Stellas, M Szabolcs, S Koul, Z Li, A Polyzos, C Anagnostopoulos, ... Journal of the National Cancer Institute 106 (12), dju320, 2014 | 93 | 2014 |
| SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors E Terpos, D Stellas, M Rosati, TN Sergentanis, X Hu, M Politou, V Pappa, ... European Journal of Internal Medicine 89, 87-96, 2021 | 73 | 2021 |
| A proof-of-concept study on the therapeutic potential of au nanoparticles radiolabeled with the alpha-emitter actinium-225 EA Salvanou, D Stellas, C Tsoukalas, B Mavroidi, M Paravatou-Petsotas, ... Pharmaceutics 12 (2), 188, 2020 | 61 | 2020 |
| Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer E Mameishvili, I Serafimidis, S Iwaszkiewicz, M Lesche, S Reinhardt, ... Proceedings of the National Academy of Sciences 116 (41), 20679-20688, 2019 | 56 | 2019 |
| Prox1 suppresses the proliferation of neuroblastoma cells via a dual action in p27-Kip1 and Cdc25A IP Foskolou, D Stellas, I Rozani, MD Lavigne, PK Politis Oncogene 32 (8), 947-960, 2013 | 55 | 2013 |
| 68Ga-radiolabeled AGuIX nanoparticles as dual-modality imaging agents for PET/MRI-guided radiation therapy P Bouziotis, D Stellas, E Thomas, C Truillet, C Tsoukalas, F Lux, ... Nanomedicine 12 (13), 1561-1574, 2017 | 52 | 2017 |
| Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: from prediction to druggability GC Eptaminitaki, D Stellas, B Bonavida, S Baritaki Drug Resistance Updates 65, 100866, 2022 | 51 | 2022 |
| Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study E Terpos, M Politou, TN Sergentanis, A Mentis, M Rosati, D Stellas, J Bear, ... Microorganisms 8 (12), 1885, 2020 | 48 | 2020 |
| Chimeric lipid/block copolymer nanovesicles: Physico-chemical and bio-compatibility evaluation N Pippa, D Stellas, A Skandalis, S Pispas, C Demetzos, M Libera, ... European Journal of Pharmaceutics and Biopharmaceutics 107, 295-309, 2016 | 43 | 2016 |
| Ultrasmall particles for Gd‐MRI and 68Ga‐PET dual imaging C Truillet, P Bouziotis, C Tsoukalas, J Brugière, M Martini, L Sancey, ... Contrast media & molecular imaging 10 (4), 309-319, 2015 | 40 | 2015 |
| Delta-like ligand-4-notch signaling inhibition regulates pancreatic islet function and insulin secretion F Billiard, S Karaliota, B Wang, D Stellas, I Serafimidis, A Manousopoulou, ... Cell reports 22 (4), 895-904, 2018 | 36 | 2018 |
| Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo T Stivarou, D Stellas, G Vartzi, D Thomaidou, E Patsavoudi Cancer biology & therapy 17 (8), 799-812, 2016 | 36 | 2016 |
